BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23254153)

  • 1. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
    Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
    Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
    Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in women with or at risk for HIV.
    Phelps RM; Smith DK; Heilig CM; Gardner LI; Carpenter CC; Klein RS; Jamieson DJ; Vlahov D; Schuman P; Holmberg SD;
    Int J Cancer; 2001 Dec; 94(5):753-7. PubMed ID: 11745473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
    Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
    HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term incidence of cervical cancer in women with human immunodeficiency virus.
    Massad LS; Seaberg EC; Watts DH; Minkoff H; Levine AM; Henry D; Colie C; Darragh TM; Hessol NA
    Cancer; 2009 Feb; 115(3):524-30. PubMed ID: 19127538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.
    Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G;
    Oral Oncol; 2014 Dec; 50(12):1169-76. PubMed ID: 25301563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies.
    Kadhel P; Multigner L; Bardinet F; Goerger-Sow M; Janky E
    HIV Med; 2012 Jan; 13(1):79-82. PubMed ID: 21819528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer incidence after up to 20 years of observation among women with HIV.
    Massad LS; Hessol NA; Darragh TM; Minkoff H; Colie C; Wright RL; Cohen M; Seaberg EC
    Int J Cancer; 2017 Oct; 141(8):1561-1565. PubMed ID: 28670714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
    Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
    HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HIV infection on invasive cervical cancer in Kenyan women.
    Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
    AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program.
    Massad LS; Seaberg EC; Watts DH; Hessol NA; Melnick S; Bitterman P; Anastos K; Silver S; Levine AM; Minkoff H
    AIDS; 2004 Jan; 18(1):109-13. PubMed ID: 15090836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain.
    Mayans MV; Maguire A; Miret M; Casabona J
    Sex Transm Dis; 1999 Oct; 26(9):500-3. PubMed ID: 10534202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
    Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
    PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.
    Dorrucci M; Suligoi B; Serraino D; Tirelli U; Rezza G;
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):377-80. PubMed ID: 11317082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of invasive cervical cancer among women with, or at risk for, HIV infection.
    Serraino D; Carrieri P; Pradier C; Bidoli E; Dorrucci M; Ghetti E; Schiesari A; Zucconi R; Pezzotti P; Dellamonica P; Franceschi S; Rezza G
    Int J Cancer; 1999 Jul; 82(3):334-7. PubMed ID: 10399949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.
    Silverberg MJ; Lau B; Justice AC; Engels E; Gill MJ; Goedert JJ; Kirk GD; D'Souza G; Bosch RJ; Brooks JT; Napravnik S; Hessol NA; Jacobson LP; Kitahata MM; Klein MB; Moore RD; Rodriguez B; Rourke SB; Saag MS; Sterling TR; Gebo KA; Press N; Martin JN; Dubrow R;
    Clin Infect Dis; 2012 Apr; 54(7):1026-34. PubMed ID: 22291097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    Rojas Rojas T; Poizot-Martin I; Rey D; Duvivier C; Bani-Sadr F; Cabie A; Delobel P; Jacomet C; Allavena C; Ferry T; Pugliese P; Valantin MA; Lamaury I; Hustache-Matthieu L; Fresard A; Houyou T; Huleux T; Cheret A; Makinson A; Obry-Roguet V; Lions C; Carrieri MP; Protopopescu C;
    PLoS One; 2022; 17(3):e0261069. PubMed ID: 35333883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.